Solid Biosciences Inc. Public Float
Solid Biosciences Inc. (SLDB) had Public Float of $317.70 million as of 2025-06-30, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-19
- 2025-06-30: Entity Public Float $317.70M.
- 2024-06-28: Entity Public Float $130.30M.
- 2023-06-30: Entity Public Float $51.50M.
- 2022-06-30: Entity Public Float $46.20M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $317.70M 10-K · filed 2026-03-19 |
| 2024-06-28 | $130.30M 10-K · filed 2025-03-06 |
| 2023-06-30 | $51.50M 10-K · filed 2024-03-13 |
| 2022-06-30 | $46.20M 10-K · filed 2023-03-23 |
| 2021-06-30 | $271.50M 10-K · filed 2022-03-14 |
| 2020-06-30 | $72.80M 10-K · filed 2021-03-15 |
| 2019-06-28 | $100.90M 10-K · filed 2020-03-12 |
| 2018-06-29 | $598.70M 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |